These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8707427)

  • 1. Sudden cardiac death in hypertrophic cardiomyopathy: risk evaluation.
    Mittal SR
    Int J Cardiol; 1995 Nov; 52(1):1-4. PubMed ID: 8707427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Burden of Sudden Death Associated With Hypertrophic Cardiomyopathy.
    Aro AL; Nair SG; Reinier K; Jayaraman R; Stecker EC; Uy-Evanado A; Rusinaru C; Jui J; Chugh SS
    Circulation; 2017 Oct; 136(17):1665-1667. PubMed ID: 29061579
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Adamczak DM; Oko-Sarnowska Z
    Cardiol Rev; 2018; 26(3):145-151. PubMed ID: 29621050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno Blanes JR; Mahon NG; Poloniecki JD; McKenna WJ
    Lancet; 2001 Feb; 357(9254):420-4. PubMed ID: 11273061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.
    Anastasakis A; Theopistou A; Rigopoulos A; Kotsiopoulou C; Georgopoulos S; Fragakis K; Sevdalis E; Stefanadis C
    Hellenic J Cardiol; 2013; 54(4):281-8. PubMed ID: 23912920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Norrish G; Cantarutti N; Pissaridou E; Ridout DA; Limongelli G; Elliott PM; Kaski JP
    Eur J Prev Cardiol; 2017 Jul; 24(11):1220-1230. PubMed ID: 28482693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016].
    Dubourg O; Charron P; Sirol M; Siam-Tsieu V; Mansencal N
    Presse Med; 2016 Oct; 45(10):903-910. PubMed ID: 27234906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden cardiac death in young athletes.
    Mortazavi M
    Adv Pediatr; 2013; 60(1):201-15. PubMed ID: 24007846
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: management issues in the new millennium.
    Thaman R; Firoozi S; Hamid MS; McKenna WJ
    Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden cardiac death in athletes.
    Tripathi BK; Gupta B; Agarwal AK
    J Assoc Physicians India; 2001 Jun; 49():643-9. PubMed ID: 11584942
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott P; McKenna W
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):443-51. PubMed ID: 23022709
    [No Abstract]   [Full Text] [Related]  

  • 13. Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Pelliccia F; Gersh BJ; Camici PG
    Circulation; 2021 Jan; 143(2):101-103. PubMed ID: 33428428
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients.
    El-Saiedi SA; Seliem ZS; Esmail RI
    Cardiol Young; 2014 Aug; 24(4):702-8. PubMed ID: 23895893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart.
    Saberi S; Day SM
    Circulation; 2018 Jan; 137(5):419-421. PubMed ID: 29378753
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of sudden death in end-stage hypertrophic cardiomyopathy.
    Kawarai H; Kajimoto K; Minami Y; Hagiwara N; Kasanuki H
    J Card Fail; 2011 Jun; 17(6):459-64. PubMed ID: 21624733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Athlete's heart and hypertrophic cardiomyopathy: contribution on clinical and morphologic differentiation].
    Bahlmann E; Kuck KH; Nienaber CA
    Dtsch Med Wochenschr; 2015 Jul; 140(15):1158-64. PubMed ID: 26230069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitral valve abnormalities in decedents of sudden cardiac death due to hypertrophic cardiomyopathy and idiopathic left ventricular hypertrophy.
    Bhatia RT; Khoury S; Westaby J; Behr ER; Papadakis M; Sharma S; Finocchiaro G; Sheppard MN
    Heart Rhythm; 2022 Oct; 19(10):1684-1685. PubMed ID: 35500788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.